ES2063013T3 - Procedimiento para eliminar pirogenos. - Google Patents

Procedimiento para eliminar pirogenos.

Info

Publication number
ES2063013T3
ES2063013T3 ES88117146T ES88117146T ES2063013T3 ES 2063013 T3 ES2063013 T3 ES 2063013T3 ES 88117146 T ES88117146 T ES 88117146T ES 88117146 T ES88117146 T ES 88117146T ES 2063013 T3 ES2063013 T3 ES 2063013T3
Authority
ES
Spain
Prior art keywords
pyrogens
eliminating
procedure
solution
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88117146T
Other languages
English (en)
Inventor
Tadashi Sato
Taizo Watanabe
Satoshi Minobe
Takashi Nishimura
Masahiro Kagotani
Tomonobu Ase
Zenjiro Honda
Shinji Nagamatsu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daicel Corp
Tanabe Seiyaku Co Ltd
Original Assignee
Tanabe Seiyaku Co Ltd
Daicel Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co Ltd, Daicel Chemical Industries Ltd filed Critical Tanabe Seiyaku Co Ltd
Application granted granted Critical
Publication of ES2063013T3 publication Critical patent/ES2063013T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
    • B01D61/14—Ultrafiltration; Microfiltration
    • B01D61/145—Ultrafiltration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
    • A61L2/022—Filtration
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • C—CHEMISTRY; METALLURGY
    • C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
    • C02F1/00—Treatment of water, waste water, or sewage
    • C02F1/44—Treatment of water, waste water, or sewage by dialysis, osmosis or reverse osmosis
    • C02F1/444—Treatment of water, waste water, or sewage by dialysis, osmosis or reverse osmosis by ultrafiltration or microfiltration

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Water Supply & Treatment (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Environmental & Geological Engineering (AREA)
  • Hydrology & Water Resources (AREA)
  • Analytical Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Medicinal Preparation (AREA)
  • Water Treatment By Sorption (AREA)

Abstract

LOS PIROGENOS SE ELIMINAN DE UNA DISOLUCION DE LOS MISMOS (1) TRATANDO LA DISOLUCION CON UNA MEMBRANA Y LUEGO (2) TRATANDO LA DISOLUCION RESULTANTE CON UN ABSORBENTE DE PIROGENOS. LA DISOLUCION OBTENIDA ES UTIL EN EL CAMPO FARMACEUTICO.
ES88117146T 1987-10-16 1988-10-14 Procedimiento para eliminar pirogenos. Expired - Lifetime ES2063013T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP26137087 1987-10-16
JP63221877A JPH0829316B2 (ja) 1987-10-16 1988-09-05 パイロジェンの除去方法

Publications (1)

Publication Number Publication Date
ES2063013T3 true ES2063013T3 (es) 1995-01-01

Family

ID=26524551

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88117146T Expired - Lifetime ES2063013T3 (es) 1987-10-16 1988-10-14 Procedimiento para eliminar pirogenos.

Country Status (7)

Country Link
US (1) US4909942A (es)
EP (1) EP0312104B1 (es)
JP (1) JPH0829316B2 (es)
KR (1) KR910004581B1 (es)
CA (1) CA1330049C (es)
DE (1) DE3887812T2 (es)
ES (1) ES2063013T3 (es)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5589591A (en) * 1986-07-03 1996-12-31 Advanced Magnetics, Inc. Endotoxin-free polysaccharides
US5032281A (en) * 1989-08-09 1991-07-16 Daicel Chemical Industries, Ltd. Separating membrane and separation method
US5136032A (en) * 1989-12-07 1992-08-04 Daicel Chemical Industries, Ltd. Method for separating phosphopolyol compounds using a separating agent
US5104546A (en) * 1990-07-03 1992-04-14 Aluminum Company Of America Pyrogens separations by ceramic ultrafiltration
DE4029088C1 (es) * 1990-09-13 1992-02-13 Fresenius Ag, 6380 Bad Homburg, De
US5242595A (en) * 1991-04-25 1993-09-07 U.S. Filter/Illinois Water Treatment, Inc. Bacteria removal by ceramic microfiltration
US5731164A (en) * 1991-08-06 1998-03-24 Sanorell Pharma Gmbh & Co. method of checking the rate of removal of pyrogenic substances, in particular viruses, from organic material
ES2104855T3 (es) * 1991-12-24 1997-10-16 Wako Pure Chem Ind Ltd Procedimiento para extraer endotoxinas.
AUPN030794A0 (en) 1994-12-22 1995-01-27 Aruba International Pty Ltd Discontinuous plasma or serum delipidation
IT1275427B (it) * 1995-05-16 1997-08-07 Bracco Spa Processo per la depirogenazione di soluzioni farmaceutiche iniettabili
IT1279209B1 (it) * 1995-05-16 1997-12-04 Bellco Spa Filtro dializzatore/reattore atto ad effettuare la cattura di endotossine, e procedimento per la sua realizzazione.
DE19609479A1 (de) * 1996-03-11 1997-09-18 Biotechnolog Forschung Gmbh Endotoxin-spezifische Membranen
DE19736472C1 (de) * 1997-08-21 1999-04-22 Bernhard Dr Sixt Verfahren zum Herstellen von weitgehend nebenwirkungsfreien Kontrastmitteln
EP1180241A4 (en) * 1999-05-25 2003-03-05 Univ Nebraska METHOD FOR DETECTING AND QUANTIFYING ENDOTOXINS
US6585890B2 (en) 2000-02-04 2003-07-01 Applied Research Associates, Inc. Process for producing sterile water for injection from potable water
US6716970B2 (en) * 2000-04-21 2004-04-06 Adjuvant Pharmaceuticals, Llc Water soluble, randomly substituted partial N-partial O-acetylated chitosan, preserving compositions containing chitosan, and processes for making thereof
CN1180873C (zh) * 2000-05-18 2004-12-22 诺维信公司 用活性炭进行微过滤
AUPQ846900A0 (en) * 2000-06-29 2000-07-27 Aruba International Pty Ltd A vaccine
US7407662B2 (en) * 2000-06-29 2008-08-05 Lipid Sciences, Inc. Modified viral particles with immunogenic properties and reduced lipid content
US7407663B2 (en) * 2000-06-29 2008-08-05 Lipid Sciences, Inc. Modified immunodeficiency virus particles
US7439052B2 (en) * 2000-06-29 2008-10-21 Lipid Sciences Method of making modified immunodeficiency virus particles
US20090017069A1 (en) * 2000-06-29 2009-01-15 Lipid Sciences, Inc. SARS Vaccine Compositions and Methods of Making and Using Them
US6991727B2 (en) * 2001-06-25 2006-01-31 Lipid Sciences, Inc. Hollow fiber contactor systems for removal of lipids from fluids
US20060060520A1 (en) * 2001-06-25 2006-03-23 Bomberger David C Systems and methods using a solvent for the removal of lipids from fluids
WO2003000373A1 (en) * 2001-06-25 2003-01-03 Lipid Sciences, Inc. Systems and methods using a solvent for the removal of lipids from fluids
WO2003000372A2 (en) * 2001-06-25 2003-01-03 Lipid Sciences, Inc. Systems and methods using multiple solvents for the removal of lipids from fluids
US20030127386A1 (en) * 2001-06-25 2003-07-10 Bomberger David C. Hollow fiber contactor systems for removal of lipids from fluids
US7122149B2 (en) * 2002-07-12 2006-10-17 Applied Research Associates, Inc. Apparatus and method for continuous depyrogenation and production of sterile water for injection
EP1534243A4 (en) * 2002-08-26 2008-08-13 Lipid Sciences Inc TREATMENT OF ALZHEIMER WITH ENTLIPIDED PROTEIN PARTICLES
US7393826B2 (en) * 2003-07-03 2008-07-01 Lipid Sciences, Inc. Methods and apparatus for creating particle derivatives of HDL with reduced lipid content
PT1641421T (pt) 2003-07-03 2019-03-27 Hdl Therapeutics Inc Métodos e dispositivos para criar derivados de partículas de hdl com conteúdo de lípidos reduzido
US7125967B2 (en) * 2003-10-08 2006-10-24 Adjuvant Pharmaceuticals, Llc Water-soluble chitosan having low endotoxin concentration and methods for making and using the same
US6960803B2 (en) * 2003-10-23 2005-11-01 Silicon Storage Technology, Inc. Landing pad for use as a contact to a conductive spacer
CN104190387B (zh) * 2014-09-11 2016-08-17 福州新北生化工业有限公司 一种除液体中热原的凝胶及其制备方法和应用
CN105251049B (zh) * 2015-09-29 2018-04-10 浙江星月生物科技股份有限公司 一种去除生物医用材料中细菌内毒素的离子缓冲液及应用
US11027052B2 (en) 2017-11-22 2021-06-08 HDL Therapuetics, Inc. Systems and methods for priming fluid circuits of a plasma processing system
EP3731814A4 (en) 2017-12-28 2021-09-29 HDL Therapeutics, Inc. PROCESSES FOR THE STORAGE AND ADMINISTRATION OF HIGH DENSITY PRE-BETA LIPOPROTEINS EXTRACTED FROM HUMAN PLASMA

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4261834A (en) * 1978-05-18 1981-04-14 Millipore Corporation Device and process for removing pyrogens from aqueous solutions
US4276177A (en) * 1979-08-13 1981-06-30 Vaponics Inc. High efficiency filtration with impurity concentration and ultrafiltration rejection flow recirculation
US4412985A (en) * 1980-10-06 1983-11-01 Edward Shanbrom Depyrogenation process
DE3173019D1 (en) * 1980-12-02 1986-01-02 Tracor Preparation of infusion grade water
GB2092470B (en) * 1981-02-10 1984-07-18 Tanabe Seiyaku Co Method for reducing the pyrogen content of or removing pyrogens from solutions contaminated therewith
AU540708B2 (en) * 1982-01-25 1984-11-29 Mitsubishi Rayon Company Limited Water purifying method and system
EP0110580A3 (en) * 1982-11-03 1986-06-11 Gelman Sciences, Inc. Improved process for removing pyrogens utilizing a hydrophobic microporous membrane
JPS59162991A (ja) * 1983-03-07 1984-09-13 Mitsubishi Rayon Co Ltd 水処理システム
JPS59196794A (ja) * 1983-04-20 1984-11-08 Toyo Soda Mfg Co Ltd 脱エンド・トキシン方法
JPS6013215U (ja) * 1983-07-04 1985-01-29 株式会社クラレ 飲料水製造装置
US4610790A (en) * 1984-02-10 1986-09-09 Sterimatics Company Limited Partnership Process and system for producing sterile water and sterile aqueous solutions
JPS6118493A (ja) * 1984-07-04 1986-01-27 Hitachi Ltd 純水製造装置における微生物汚染防止装置

Also Published As

Publication number Publication date
KR890006221A (ko) 1989-06-12
DE3887812T2 (de) 1994-05-19
EP0312104A3 (en) 1989-08-09
JPH01194991A (ja) 1989-08-04
US4909942A (en) 1990-03-20
EP0312104A2 (en) 1989-04-19
CA1330049C (en) 1994-06-07
DE3887812D1 (de) 1994-03-24
KR910004581B1 (ko) 1991-07-06
JPH0829316B2 (ja) 1996-03-27
EP0312104B1 (en) 1994-02-16

Similar Documents

Publication Publication Date Title
ES2063013T3 (es) Procedimiento para eliminar pirogenos.
ES2075202T3 (es) Nuevas arilpiridazinas, su preparacion, su utilizacion, y medicamentos que las contienen.
IT1209603B (it) Derivati 2,6-disostituiti di naftalene, procedimento per prepararli e loro uso nel campo farmaceutico e cosmetico.
DE69129800D1 (de) Behandlung von menschlichen retrovirus-infektionen mit 2',3'-dideoxyinosin
ES2171158T3 (es) Derivados de oxatiolano cristalizados.
ES2161291T3 (es) N-(indol-2-carbonil)amidas y derivados como inhibidores de la glucogeno fosforilasa.
ES2144192T3 (es) Nuevos derivados de 1-fenil-2-dimetil-amino-metil-ciclohexan-1-ol, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
MX9200180A (es) DERIVADOS DE LA 5H-PIRROL (3,4-b) PIRAZINA OPTICAMENTE ACTIVOS, PROCEDIMIENTO PARA SU PREPARACION Y COMPOSICION FARMACEUTICA QUE LOS CONTIENE.
AR003938A1 (es) Compuestos triciclicos de urea utiles para la inhibicion de la funcion de la proteina g y para tratamiento de enfermedades proteoliticas, composicionfarmaceutica, y el uso de los mismos para la preparacion de medicamentos.
ES2060399T3 (es) Cristales de la hormona del crecimiento y procedimiento para la produccion de estos cristales de la hormona del crecimiento.
ES2075050T3 (es) Peptidos que tienen actividad cooperadora de celulas t.
ES2026126T3 (es) Un sistema para la toma, tratamiento y devolucion de sangre de un paciente.
YU47116B (sh) Postupak za dobijanje novih n-supstituisanih benzimidazolskih derivata
ES2051678T1 (es) Derivados de 5-oxo-l-prolina y uso farmaceutico de los mismos.
ES2101230T3 (es) Nuevos derivados de sustancias anti-inflamatorias, analgesicas y/o antipireticas no estereoideas, su uso y formulaciones farmaceuticas que las contienen.
ATE147981T1 (de) Verabreichung von lamotrigin zur behandlung von neuro-aids
IE900098L (en) The use of the active substance azelastine in combatting¹psoriasis disorders and inflammatory disorders
ES2130152T3 (es) Medicamentos para tratar dolencias inflamatorias o para analgesia que contienen un nsaid y ranitidina/citrato de bismuto.
DE3582594D1 (de) Proglumid und dessen pharmazeutische zusammensetzungen zur anwendung bei der behandlung von neoplastischen affektionen.
MX9301235A (es) DERIVADOS 1,4-DIOXINO(2,3-B)PIRIDINA. á
SE8302580D0 (sv) Substituerade iminoderivat av dihydrobensopyran och dihydrobensotiopyran och forfarande for deras framstellning
KR850008664A (ko) 4-아미노-n-(1-페닐에틸)벤즈아미드의(s)-및(r)-에난티오머의 제조방법
ES2122962T3 (es) Derivados de alquileno-dioxibenceno opticamente activos y su uso en terapia.
ES2086195T3 (es) Nuevos derivados pseudopeptidicos de actividad antagonista de la bradiquinina, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
EA199900363A1 (ru) Новые производные пентаэритрита, их получение и применение, а также промежуточные продукты для их синтеза

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 312104

Country of ref document: ES